V Apostolopoulos Selected Research

SB 328437

11/2018

Targeting eotaxin-1 and CCR3 receptor alleviates enteric neuropathy and colonic dysfunction in TNBS-induced colitis in guinea pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V Apostolopoulos Research Topics

Disease

9	Neoplasms (Cancer) 01/2011 - 01/2000
4	Adenocarcinoma 01/2015 - 07/2000
2	Inflammation (Inflammations) 11/2018 - 01/2015
2	Malaria 03/2002 - 08/2000
1	Pain (Aches) 01/2021
1	Periprosthetic Fractures 01/2021
1	Infections 01/2021
1	Colitis 11/2018
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 11/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2006
1	Lung Neoplasms (Lung Cancer) 02/2006
1	Carcinoma (Carcinomatosis) 02/2006
1	Small Cell Carcinoma 02/2006
1	Leukemia 01/2006
1	Lymphoma (Lymphomas) 01/2006
1	Communicable Diseases (Infectious Diseases) 02/2002
1	Multiple Sclerosis 09/2001
1	Hypertension (High Blood Pressure) 07/2001
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2000
1	Breast Neoplasms (Breast Cancer) 02/2000
1	Necrosis 02/2000

Drug/Important Bio-Agent (IBA)

5	Peptides (Polypeptides)IBA 01/2006 - 02/2000
4	VaccinesIBA 01/2006 - 08/2000
3	Interleukin-10 (Interleukin 10)IBA 01/2011 - 02/2000
3	CytokinesIBA 01/2011 - 02/2000
3	AntigensIBA 01/2006 - 01/2000
2	Hormones (Hormone)IBA 01/2011 - 07/2001
2	Interleukin-6 (Interleukin 6)IBA 02/2006 - 02/2000
2	Mannose ReceptorIBA 02/2006 - 07/2000
2	Proteins (Proteins, Gene)FDA Link 01/2006 - 01/2005
2	Histocompatibility Antigens Class IIBA 01/2005 - 07/2000
2	MucinsIBA 10/2001 - 02/2000
1	salicylhydroxamic acid (SHAM)IBA 11/2018
1	SB 328437IBA 11/2018
1	Ethanol (Ethyl Alcohol)IBA 11/2018
1	Trinitrobenzenesulfonic AcidIBA 11/2018
1	CCR3 ReceptorsIBA 11/2018
1	Chemokine CCL11IBA 11/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2015
1	Chemotactic FactorsIBA 01/2015
1	InterleukinsIBA 01/2015
1	Interleukin-8 (Interleukin 8)IBA 01/2015
1	LipopolysaccharidesIBA 01/2015
1	Macrophage Colony-Stimulating FactorIBA 01/2011
1	GangliosidesIBA 01/2011
1	Dinoprostone (PGE2)FDA Link 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	ProstaglandinsIBA 01/2011
1	ChemokinesIBA 01/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2011
1	Polystyrenes (Polystyrene)IBA 02/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2006
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2006
1	Interleukin-1 (Interleukin 1)IBA 02/2006
1	AntibodiesIBA 01/2006
1	EpitopesIBA 03/2002
1	Merozoite Surface Protein 1 (MSA1)IBA 03/2002
1	Vasoconstrictor AgentsIBA 07/2001
1	Angiotensin IIIBA 07/2001
1	Interleukin-12 (IL 12)IBA 09/2000
1	MannansIBA 07/2000
1	Aspartic Acid (Aspartate)FDA Link 04/2000
1	HLA-DQ Antigens (HLA-DQ)IBA 04/2000
1	Cytokine Receptors (Cytokine Receptor)IBA 02/2000
1	Interleukin-4 (Interleukin 4)IBA 02/2000
1	Interleukin-2 (IL2)IBA 02/2000
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 02/2000

Therapy/Procedure

5	Immunotherapy 01/2011 - 02/2000
1	Reoperation 01/2021
1	Therapeutics 09/2001